Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibition.
about
Dasatinib induces autophagy in mice with Bcr-Abl-positive leukemia.Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells.Phosphorylation of Tyr245 in the open-inhibited state of Abelson kinase does not induce downstream signaling.Prolonged cellular midostaurin retention suggests potential alternative dosing strategies for FLT3-ITD-positive leukemias.Sustained inhibition of STAT5, but not JAK2, is essential for TKI-induced cell death in chronic myeloid leukemia.Determination of Imatinib in the Blood Cells of Chronic Myelogenous Leukemia Patients by Ion-Trap Mass Spectrometry
P2860
Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibition.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Apoptosis in chronic myeloid l ...... ual BCR-ABL kinase inhibition.
@en
Apoptosis in chronic myeloid l ...... ual BCR-ABL kinase inhibition.
@nl
type
label
Apoptosis in chronic myeloid l ...... ual BCR-ABL kinase inhibition.
@en
Apoptosis in chronic myeloid l ...... ual BCR-ABL kinase inhibition.
@nl
prefLabel
Apoptosis in chronic myeloid l ...... ual BCR-ABL kinase inhibition.
@en
Apoptosis in chronic myeloid l ...... ual BCR-ABL kinase inhibition.
@nl
P2093
P2860
P356
P1476
Apoptosis in chronic myeloid l ...... dual BCR-ABL kinase inhibition
@en
P2093
David Potesil
Irena Koutna
Jiri Mayer
Lenka Tesarova
Michaela Potesilova
Pavel Simara
Zbynek Zdrahal
P2860
P304
P356
10.1002/AJH.23419
P50
P577
2013-03-27T00:00:00Z